Leaflet OXALIPLATINA AQVIDA 5mg / ml concentrate for solution for infusion
Indicated for: colorectal cancer
Route of administration: infusion
Substance: oxaliplatin (antineoplastic agent)
ATC: L01XA03 (Antineoplastic and immunomodulating agents | Other antineoplastic agents | Platinum compounds)
This medicine may affect fertility.
Dose adjustment may be needed in liver disease.
Handle with special care.
Effective contraception is required during treatment.
Do not use this medicine while breastfeeding.
Do not use this medicine during pregnancy.
This medicine may affect the liver.
This medicine may have important interactions with other medicines.
This medicine may lower blood cell counts.
This medicine is subject to additional monitoring.
Periodic laboratory tests may be required during treatment.
This medicine may affect the kidneys.
This medicine may affect the nerves or nervous system.
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Oxaliplatin is a chemotherapy agent used in the treatment of advanced or metastatic colorectal cancer. It works by binding to the DNA of tumor cells, inhibiting their replication and causing cell death.
The medication is administered intravenously, as directed by a doctor, usually in combination with other chemotherapy drugs. It is important for patients to follow the treatment regimen and undergo regular tests to monitor the therapy's effects.
Patients should be aware of potential side effects, such as peripheral neuropathy, nausea, or diarrhea. It is important to inform the doctor of any unusual symptoms.
Common side effects include peripheral neuropathy, nausea, and diarrhea. In rare cases, severe reactions such as myelosuppression or allergic reactions may occur. Patients should be informed of these risks before use.
General data about OXALIPLATINA AQVIDA 5mg / ml
- Substance: oxaliplatin
- Date of last drug list: 01-05-2026
- Commercial code: W71819001
- Concentration: 5mg / ml
- Pharmaceutical form: concentrate for solution for infusion
- Quantity: 1
- Product type: generic
- Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).